Keysight Technologies, Inc. · Technology
The price already needs more growth than analysts forecast, at both a 9% and an 8% discount rate.
At a 24.5% margin the price needs +16.9% 3y revenue CAGR against +12.5% consensus, a cushion of -14.5pt versus a 3.1pt correction cut. The price already asks for more than consensus before any correction, so it drowns; Moderate capex channel.
Would recover if: Consensus growth rises toward 17% or the margin proves durable near consensus 32% (e.g. SBC falls materially), lifting the cushion above zero.. We re-check this against analyst estimates every evening.
10 years, at a 25% margin analysts expect
+8.4%/yr over 10 years once faded to terminal growth
points off 3-year analyst growth
17 published targets, set before the drop
Does the profit analysts build their margin on actually arrive as cash? Measured over the last 3 annual statements filed before this test. After stock-based pay, 128% of reported profit arrived as operating cash, so the analysts' margin stands.
How much of reported profit arrived as operating cash. Below 0.8× is a red flag.
Profit not backed by cash, as a share of assets, latest year. Above 10% is a red flag.
Staff paid in shares instead of cash, which flatters margins. Above 10% is a red flag.
Dilution of each share's claim on the business. Above 3% a year is a red flag.
Non-operating gains in the latest year. Above 25% is a red flag.
After capex. Shown for context: heavy investment is not bad earnings, so it is never solved under.
From the priced-in reconstruction of Sep 10, 2026. Its figures use that day's price and free-cash-flow margin, so they can differ from the stress test above.
The price at the price sits at the 6th percentile of published models, meaning the market has largely rejected the 14 bull cases that target 16-33% upside and is only paying for the continuation of current, slower growth.
The price assumes the current 8% growth rate persists; the question is whether AI-driven testing demand can actually accelerate revenue to the 16% rate the stock needs, and the available data can only measure past segment volumes, not the forward order book that would settle this.
What the price refuses to pay for, and the full reconstruction, on the KEYS quote page →A stress test of whether this narrative is still paid for by analyst forecasts, not a forecast that the stock will rise. The price-implied growth on its own has not predicted returns in our testing, and this list (sealed Nov 21, 2026) has not been graded yet. Cut sizes are assumptions. Not investment advice. Back to all names